MedTrace Logo

Comparative Validation of the Growth Hormone Releasing Hormone and Arginine Test for the Diagnosis of Adult Growth Hormone Deficiency

NCT01060488 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2014-08-05

No results posted yet for this study

Summary

The aim of the study is to determine the specificity and sensitivity of the combined growth hormone releasing hormone (GHRH) + Arginine test in healthy volunteers, subjects with highly probable adult growth hormone deficiency (AGHD) and subjects who were probably free of AGHD.

Conditions

  • Growth Hormone Deficiency

Interventions

OTHER

GHRH+Arg, GHRH+Arg, ITT

GHRH+Arg repeatability test (2 tests) + comparison with one IT test

OTHER

ITT, ITT, GHRH+Arg.

IT repeatability test (2 tests) + comparison with one GHRH+Arg test

Sponsors & Collaborators

  • Merck KGaA, Darmstadt, Germany

    lead INDUSTRY

Principal Investigators

  • Philippe Chanson, MD, Professor · CHU Bicêtre, Endocrinology and Reproductive Diseases Department

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-01-31
Primary Completion
2005-11-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01060488 on ClinicalTrials.gov